SINGLETON J MATTHEW

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$186,521.10
Insider Sells Quantity
5
Insider Sells Sum
$4.58M

Insider Activity of SINGLETON J MATTHEW

According to the SEC Form 4 filings, SINGLETON J MATTHEW, being in a position of

  1. director at Viking Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 68786 shares for $4.58M,
    over all time since 2018-05-31, has bought 19000 shares for $186,521, and sold 68786 shares for $4.58M.

The largest purchase of all time was on 2018-05-31 and amounted to 19000 shares of Viking Therapeutics, Inc. for $186,521.

The largest sale of all time was on 2024-10-25 and amounted to 16000 shares of Viking Therapeutics, Inc. for $1.27M.

Biography of SINGLETON J MATTHEW

No biography is available at this moment.

2024-10-25SaleViking Therapeutics, Inc.
VKTX
director
16,000
0.0185%
$79.50$1.27M0%
2024-09-20SaleViking Therapeutics, Inc.
VKTX
director
10,300
0.0092%
$69.50$715,850-7.82%
2024-08-21SaleViking Therapeutics, Inc.
VKTX
director
5,700
0.0055%
$69.72$397,430-0.63%
2024-08-19SaleViking Therapeutics, Inc.
VKTX
director
16,000
0.0135%
$62.22$995,453-3.27%
2024-08-14SaleViking Therapeutics, Inc.
VKTX
director
20,786
0.0186%
$57.53$1.2M0%
2018-05-31PurchaseViking Therapeutics, Inc.
VKTX
director
19,000
0.0354%
$9.82$186,521-0.2%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.